Merck & Co. (MRK) to Acquire Terns Pharma for $6.7 Billion

Merck & Co., Inc. (NYSE:MRK) is included in our list of the best stocks to buy for financial stability. Merck & Co. (NYSE) to Acquire Terns Pharma for $6.7 Billion On March 25, 2026, Merck & Co., Inc. (NYSE:MRK) came into the limelight when Reuters reported that the company had agreed to buy Terns Pharma for $6.7 billion. The move comes as the company looks to expand its cancer pipeline amid concerns surrounding the looming patent loss for blockbuster therapy Keytruda. By the end of this decade, Merck ...